Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD

Cancer Research

Volumn 62, Issue 19, 2002, Pages 5457-5462

  Aloyz, Raquel ^a   Xu, Zhi Yuan ^a   Bello, Vanessa ^a   Bergeron, Josée ^a   Han, Fei Yu ^b   Yan, Yifei ^a   Malapetsa, Areti ^a   Alaoui Jamali, Moulay A ^a   Duncan, Alessandra M V ^b   Panasci, Lawrence ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNA; MELPHALAN; PROTEIN; RAD51 PROTEIN;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; CROSS LINKING; DNA DAMAGE; DRUG RESISTANCE; EXCISION REPAIR; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SISTER CHROMATID EXCHANGE;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL NUCLEUS; CISPLATIN; DNA HELICASES; DNA REPAIR; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENDONUCLEASES; GLIOMA; HUMANS; MELPHALAN; PRECIPITIN TESTS; PROTEIN BIOSYNTHESIS; PROTEINS; RAD51 RECOMBINASE; RADIATION TOLERANCE; S PHASE; SISTER CHROMATID EXCHANGE; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 0036791141     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hoeijmakers, J. H. Genome maintenance mechanisms for preventing cancer. Nature (Lond.), 411: 366-374, 2001.
2. Panasci, L., Paiement, J. P., Christodoulopoulos, G., Belenkov, A., Malapetsa, A., and Aloyz, R. Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair. Clin. Cancer Res., 7: 454-461, 2001.
3. Chaney, S. G., and Sancar, A. DNA repair: enzymatic mechanisms and relevance to drug response. J. Natl. Cancer Inst., 88: 1346-1360, 1996.
4. Dabholkar, M., Thornton, K., Vionnet, J., Bostick-Bruton, F., Yu, J. J., and Reed, E. Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues. Biochem. Pharmacol., 60: 1611-1619, 2000.
5. Xu, Z. Y., Chen, Z. P., Malapetsa, A., Alaoui-Jamali, M., Bergeron, J., Monks, A., Myers, T. G., Mohr, G., Sausville, E. A., Scudiero, D. A., Aloyz, R., and Panasci, L. C. DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program. Anti-Cancer Drugs, 13: 511-519, 2002.
6. th data lecture. TFIIH: from transcription to clinic. FEBS Lett., 498: 124-128, 2001.
7. Damia, G., Imperatori, L., Stefanini, M., and D'Incalci, M. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents. Int. J. Cancer, 66: 779-783. 1996.
8. Hoy, C. A., Thompson. L. H., Mooney, C. L., and Salazar, E. P.[title] Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res., 45: 1737-1743, 1985.
9. Thompson, L. H., and Shild, D. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat. Res., 477: 131-153, 2001.
10. Wang, Z. M., Chen, Z. P., Xu, Z. Y., Christodoulopoulos, G., Bello, V., Mohr, G., Aloyz, R., and Panasci. L. In vitro evidence for homologous recombinational repair in resistance to melphalan. J. Natl. Cancer. Inst., 93: 1473-1478, 2001.
11. Christodoulopoulos, G., Malapetsa, A., Schipper, H., Golub, E., Radding, C., and Panasci, L. C. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia. Clin. Cancer Res., 5: 2178-2184, 1999.
12. De Jong, S., Zijlstra, J. G., Timmer-Bosscha, H., Mulder, N. H., and Vries, E. G. Detection of DNA cross-links in tumor cells with the ethidium bromide fluorescence assay. Int. J. Cancer, 37: 557-561, 1986.
13. Perry P. E., and Wolff, S. New Giemsa method for the differential staining of sister chromatids. Nature (Lond.), 258: 121-125, 1974.
14. Dignam, J. D., Lebovitz. R. M., and Roeder. R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res., 11: 1475-1489, 1983.
15. Aboussekhra, A., Biggerstaff, M., Shivji, M. K., Vilpo, J. A., Moncollin, V., Podust, V. N., Protic, M., Hubscher, U., Egly, J. M., and Wood, R. D. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell, 80: 859-868, 1995.
16. Marinoni, J. C., Rossignol. M., and Egly, J. M. Purification of the transcription/repair factor TFIIH and evaluation of its associated activities in vitro. Methods (Orlando), 12: 235-253, 1997.
17. Wood, R. D., Biggerstaff, M., and Shivji, M. K. K. Detection and measurement of nucleotide excision repair synthesis by mammalian cells extracts in vitro. Methods: A Companion to Methods in Enzymology, 7: 163-175, 1995.
18. Vogel, U., Dybdahl, M., Frentz. G., and Nexo, B. A. DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes. Mutat. Res., 461: 197-210, 2000.
19. Lim, D. S., and Hasty, P. A mutation in mouse Rad51 results in an early embryonic lethal that is suppressed by a mutation in P53. Mol. Cell. Biol., 16: 7133-7143, 1996.
20. Thompson, L. H., and Shild, D. The contribution of homologous recombination in preserving genome integrity in mammalian cells. Biochimie, 81: 87-105, 1999.
21. Tsuzuki, T., Fujii, Y., Sakumi, K., Tominaga, Y., Nakao, K., Sekiguchi, M., Matsushiro, A., Yoshimura, Y., and Morita, T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad Sci. USA, 93: 6236-6240, 1996.
22. Takata, M., Sasaki, M. S., Tachiiri, S., Fukushima, T., Sonoda, E., Schild, D., Thompson, L. H., and Takeda, S. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol. Cell. Biol. 21: 2858-2866, 2001.
23. Sonoda, E., Sasaki, M. S., Morrison. C., Yamaguchi-Iwai, Y., Takata, M., and Takeda. S, Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol. Cell. Biol., 19: 5166-5169, 1999.
24. Vispe, S., Cazaux, C., Lesca, C., and Defais, M. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res., 26: 2859-2864, 1998.
25. Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly J. M., Wang, Z., Freidberg, E. C., Evans, M. K., and Taffe, B. G. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet., 10: 188-195, 1995.
26. Sturzbecher, H. W., Donzelmanm, B., Henning, W., Knippchild, U., and Buchhop, S. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J., 15: 1992-2002, 1996.
27. Schultz, P., Fribourg, S., Poterszman, A., Mallouh, V., Moras, D., and Egly, J. M. Molecular structure of human TFIIH. Cell, 102: 599-607, 2000.
28. Kohn, K. W. Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol. Biol. Cell. 10: 2703-2734, 1999.
29. Tashiro, S., Walter, J., Shinohara, A., Kamada, N., and Cremer, T. Rad51 accumulation at sites of DNA damage and in postreplicative chromatin. J. Cell. Biol., 150: 283-291, 2000.
30. Chen, F., Nastasi, A., Shen. Z., Brenneman, M., Crissman, H., and Chen, D. J. Cell cycle-dependent protein expression of mammalian homologs of yeast DNA double-strand break repair genes Rad51 and Rad52. Mutat. Res., 384: 205-211, 1997.